Compare AMRX & HAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AMRX | HAFN |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | Singapore |
| Employees | N/A | 4876 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.4B |
| IPO Year | 2018 | N/A |
| Metric | AMRX | HAFN |
|---|---|---|
| Price | $11.92 | $8.73 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.60 | N/A |
| AVG Volume (30 Days) | 1.5M | ★ 1.5M |
| Earning Date | 05-01-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.21% |
| EPS Growth | ★ 157.89 | N/A |
| EPS | ★ 0.19 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.48 | N/A |
| Revenue Next Year | $7.13 | N/A |
| P/E Ratio | $64.32 | ★ $11.39 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.02 | $4.90 |
| 52 Week High | $15.42 | $9.54 |
| Indicator | AMRX | HAFN |
|---|---|---|
| Relative Strength Index (RSI) | 35.55 | 54.79 |
| Support Level | $11.60 | $7.95 |
| Resistance Level | $12.12 | $9.54 |
| Average True Range (ATR) | 0.40 | 0.25 |
| MACD | -0.13 | -0.07 |
| Stochastic Oscillator | 2.04 | 23.22 |
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.
Hafnia Ltd is one of the tanker owners, transporting oil, oil products and chemicals for national and international oil companies, chemical companies, as well as trading and utility companies. As owners and operators of around 200 vessels, It offers a fully integrated shipping platform, including technical management, commercial and chartering services, pool management, and a large-scale bunker procurement desk. Company manages it's business through the following reporting segments: LR2 tankers, LR1 tankers, MR tankers, Handy tankers.